月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE（每份年报一根整柱，柱宽 = 生效期：报告期 + 4 个月起）
加载中…
获利能力 Profitability (单位：美元)
| 指标 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2010 | 2011 | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率（ROE） | - | 26.79% | 27.88% | 28.33% | 25.60% | 30.17% | 26.35% | 24.88% | 17.81% | 19.92% | 22.70% | 21.87% | 1.99% | 25.51% | 25.36% | 23.97% | 30.41% | 48.29% | 20.06% | 35.03% | 22.05% | 12.93% |
| 总资产收益率（ROA） | - | 14.91% | 15.34% | 15.67% | 13.06% | 15.25% | 12.95% | 12.96% | 8.94% | 10.42% | 12.52% | 11.55% | 0.83% | 10.00% | 9.59% | 8.41% | 11.47% | 20.98% | 7.81% | 13.46% | 8.55% | 5.36% |
| 毛利率 | 71.22% | 70.91% | 71.54% | 71.76% | 70.95% | 70.96% | 70.20% | 69.49% | 67.78% | 68.67% | 69.40% | 69.27% | 66.72% | 66.79% | 66.42% | 65.58% | 70.28% | 68.82% | 69.07% | 67.88% | 67.16% | 67.27% |
| 净利率 | 18.17% | 17.19% | 17.28% | 20.73% | 17.31% | 20.31% | 19.82% | 21.65% | 15.64% | 19.40% | 21.96% | 21.99% | 1.70% | 18.75% | 18.42% | 17.82% | 26.52% | 41.28% | 15.84% | 28.46% | 36.23% | 21.81% |
| 每股收益（EPS） | 2.20 | 2.42 | 2.76 | 3.76 | 3.67 | 4.62 | 4.45 | 4.85 | 3.94 | 4.92 | 5.80 | 5.56 | 0.48 | 5.70 | 5.72 | 5.59 | 7.93 | 13.88 | 5.84 | 11.13 | 6.87 | 4.47 |
财务结构 Financial Structure
| 指标 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2010 | 2011 | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 11.14% | 17.26% | 5.79% | 9.60% | 12.68% | 16.70% | 18.81% | 12.29% | 15.77% | 11.14% | 10.29% | 11.33% | 11.84% | 10.97% | 8.00% | 7.96% | 13.05% | 13.38% | 9.89% | 9.61% | 10.16% |
| 负债占总资产比率 | - | 44.33% | 40.33% | 44.27% | 46.49% | 49.94% | 46.57% | 45.02% | 46.58% | 44.19% | 46.49% | 46.67% | 61.76% | 60.93% | 62.30% | 63.82% | 59.33% | 58.96% | 60.31% | 59.07% | 59.42% | 57.74% |
经营能力 Operating Capability
| 指标 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2010 | 2011 | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 6.37 | 6.93 | 6.12 | 6.47 | 6.56 | 6.42 | 6.30 | 5.94 | 6.09 | 6.77 | 6.53 | 5.67 | 5.79 | 5.67 | 6.08 | 5.15 | 5.73 | 5.98 | 5.48 | 2.56 | 2.59 |
| 平均收现日数 | - | 57 天 | 53 天 | 60 天 | 56 天 | 56 天 | 57 天 | 58 天 | 61 天 | 60 天 | 54 天 | 56 天 | 64 天 | 63 天 | 64 天 | 60 天 | 71 天 | 64 天 | 61 天 | 67 天 | 143 天 | 141 天 |
| 固定资产周转率(次) | - | 0.2352 | 0.2204 | 0.2446 | 0.2322 | 0.2253 | 0.2384 | 0.4940 | 0.2395 | 0.2343 | 0.2169 | 0.2270 | 0.2224 | 0.2088 | 0.2152 | 0.2272 | 0.2408 | 0.2337 | 0.2310 | 0.5772 | 1.1498 | 1.1245 |
| 总资产周转率 | - | 86.74% | 88.80% | 75.58% | 75.47% | 75.07% | 65.37% | 59.85% | 55.40% | 53.75% | 57.02% | 52.52% | 48.60% | 53.34% | 52.03% | 47.22% | 43.26% | 50.82% | 49.32% | 47.28% | 23.60% | 24.56% |
现金流量 Cash Flow (单位：亿美元)
| 指标 | 2002 | 2003 | 2005 | 2006 | 2007 | 2008 | 2010 | 2011 | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 53.77 | 92.03 | 40.83 | 77.70 | 107.68 | 158.10 | 193.55 | 149.11 | 209.27 | 145.23 | 137.32 | 178.24 | 181.07 | 173.05 | 139.85 | 144.87 | 218.59 | 241.05 | 197.09 | 185.77 | 204.22 |
| 净利润 | 65.97 | 71.97 | 81.80 | 110.53 | 105.76 | 129.49 | 122.66 | 133.34 | 108.53 | 138.31 | 163.23 | 154.09 | 13.00 | 152.97 | 151.19 | 147.14 | 208.78 | 351.53 | 140.66 | 268.04 | 165.36 | 107.69 |
| 经营活动现金流量 | 81.76 | 105.95 | 110.89 | 142.48 | 150.22 | 149.72 | 165.71 | 163.85 | 153.96 | 174.14 | 187.10 | 195.69 | 210.56 | 222.01 | 234.16 | 235.36 | 234.10 | 227.91 | 242.66 | 245.30 | 80.52 | 111.30 |
| 投资活动现金流量 | -21.97 | -45.26 | -23.47 | -202.91 | -59.12 | -41.87 | -75.98 | -78.54 | -45.10 | -51.03 | -123.05 | -77.35 | -148.68 | -31.67 | -61.94 | -208.25 | -86.83 | 8.78 | -185.99 | -235.88 | -185.61 | -21.50 |
| 筹资活动现金流量 | -69.53 | -38.63 | -51.06 | -61.09 | -56.98 | -74.64 | -40.92 | -49.80 | -205.62 | -60.91 | -124.99 | -111.36 | -76.73 | -185.10 | -180.15 | -61.20 | -140.47 | -158.25 | -31.32 | -55.39 | 47.57 | -82.47 |
| 净现金流量 | -8.64 | 24.83 | 38.26 | -119.72 | 36.87 | 29.98 | 50.42 | 35.45 | -96.31 | 60.16 | -64.04 | -7.91 | -11.48 | 2.83 | -8.02 | -33.20 | 5.02 | 77.32 | 22.46 | -43.96 | -55.28 | 7.13 |
右侧两列为报告期累计口径同比（左：去年同期同一期次，右：最近一期季报，年报期次已在左侧列展示）；周转率类指标为报告期累计值，未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD